United States · FDA National Drug Code directory
Irbesartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-731_4cd3482f-1ad1-1839-e063-6394a90a44d3
- Product NDC
- 31722-731
- Form
- TABLET
- Composition / generic term
- Irbesartan
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120927
- Source listing expiry
- 20271231
Source-listed ingredients
- IRBESARTAN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (31722-731-05) · 31722-731-05
- 1000 TABLET in 1 BOTTLE (31722-731-10) · 31722-731-10
- 30 TABLET in 1 BOTTLE (31722-731-30) · 31722-731-30
- 120 BLISTER PACK in 1 CARTON (31722-731-31) / 10 TABLET in 1 BLISTER PACK · 31722-731-31
- 90 TABLET in 1 BOTTLE (31722-731-90) · 31722-731-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →